AI assistant
Sending…
BIOGEN INC. — Director's Dealing 2026
Feb 18, 2026
30291_dirs_2026-02-17_1031058a-46ce-4c33-acda-ba751c93eafe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2026-02-13
Reporting Person: Godbout Sean (Chief Accounting Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-13 | Restricted Stock Unit | $0 | A | 1800 | Acquired | 2029-02-13 | Common Stock (1800) | Direct |
Footnotes
F1: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.
More from BIOGEN INC.
Regulatory Filings
2026
Jul 1
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 10
Regulatory Filings
2026
Jun 10
Call Transcript
2026
Jun 9
M&A Activity
2026
May 14
Call Transcript
2026
May 13
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Call Transcript
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29